禮來公司
MX ˙ BMV ˙ US5324571083
SecurityMX:LLY / Eli Lilly and Company
InstitutionKeel Point, LLC
Latest Disclosed Ownership2,671 shares
Latest Disclosed Value $ 2,456,667
Keel Point, LLC reports 34.61% decrease in ownership of LLY / Eli Lilly and Company

On May 29, 2026 - Keel Point, LLC filed a 13F-HR form disclosing ownership of 2,671 shares of Eli Lilly and Company (MX:LLY) valued at $2,456,667 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 4,085 shares of Eli Lilly and Company. This represents a change in shares of -34.61% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-29 2026-03-31 13F ELI LILLY COM 532457108 2,671 -1,414 -34.61 2,457 -44.04 0.1590
2026-02-12 2025-12-31 13F ELI LILLY COM 532457108 4,085 476 13.19 4,390 59.43 0.2645
2025-12-16 2025-09-30 13F ELI LILLY COM 532457108 3,609 21 0.59 2,753 -1.57 0.1693
2025-08-15 2025-06-30 13F ELI LILLY COM 532457108 3,588 55 1.56 2,797 -4.15 0.1849
2025-05-15 2025-03-31 13F ELI LILLY COM 532457108 3,533 532 17.73 2,918 25.99 0.2265
2025-02-14 2024-12-31 13F ELI LILLY COM 532457108 3,001 104 3.59 2,317 -9.74 0.1854
2024-11-14 2024-09-30 13F ELI LILLY COM 532457108 2,897 -122 -4.04 2,567 -6.38 0.2138
2024-08-14 2024-06-30 13F ELI LILLY COM 532457108 3,019 793 35.62 2,742 58.35 0.2475
2024-04-16 2024-03-31 13F ELI LILLY COM 532457108 2,226 166 8.06 1,732 44.25 0.1791
2024-01-30 2023-12-31 13F ELI LILLY COM 532457108 2,060 49 2.44 1,201 11.11 0.1434
2023-10-26 2023-09-30 13F ELI LILLY COM 532457108 2,011 30 1.51 1,080 16.25 0.1481
2023-07-12 2023-06-30 13F LILLY ELI COM 532457108 1,981 136 7.37 929 46.76 0.1241
2023-04-03 2023-03-31 13F LILLY ELI COM 532457108 1,845 -26 -1.39 634 -7.46 0.0916
2023-01-17 2022-12-31 13F LILLY ELI COM 532457108 1,871 172 10.12 685 24.59 0.1075
2022-10-05 2022-09-30 13F LILLY ELI COM 532457108 1,699 12 0.71 549 6.81 0.0942
2022-08-11 2022-06-30 13F LILLY ELI COM 532457108 1,687 -142 -7.76 514 -1.91 0.0801
2022-04-27 2022-03-31 13F LILLY ELI COM 532457108 1,829 -5 -0.27 524 3.35 0.0786
2022-01-31 2021-12-31 13F LILLY ELI COM 532457108 1,834 -107 -5.51 507 13.17 0.0569
2021-11-04 2021-09-30 13F LILLY ELI COM 532457108 1,941 439 29.23 448 29.86 0.0579
2021-08-06 2021-06-30 13F/A-1 LILLY ELI COM 532457108 1,502 4 0.27 345 23.21 0.0384
2021-08-06 2021-06-30 13F LILLY ELI COM 532457108 0 -1,498 203 0.0471
2021-05-17 2021-03-31 13F LILLY ELI COM 532457108 1,498 233 18.42 280 30.84 0.0273
2021-02-10 2020-12-31 13F LILLY ELI COM 532457108 1,265 -134 -9.58 214 3.38 0.0191
2020-11-18 2020-09-30 13F LILLY ELI COM 532457108 1,399 1,399 10.59 207 -3.27 0.0188
2019-05-14 2019-03-31 13F Eli Lilly COM 532457108 0 -5,190 -100.00 0 -100.00
2019-02-08 2018-12-31 13F Eli Lilly COM 532457108 5,190 0 0.00 601 7.90 0.0814
2018-11-07 2018-09-30 13F Eli Lilly COM 532457108 5,190 514 10.99 557 39.60 0.0692
2018-08-13 2018-06-30 13F Eli Lilly COM 532457108 4,676 -2,100 -30.99 399 -23.85 0.0531
2018-05-07 2018-03-31 13F Eli Lilly COM 532457108 6,776 -789 -10.43 524 -18.00 0.0717
2018-02-08 2017-12-31 13F Eli Lilly COM 532457108 7,565 -200 -2.58 639 -3.77 0.0884
2017-11-09 2017-09-30 13F Eli Lilly COM 532457108 7,765 0 0.00 664 3.91 0.1011
2017-08-15 2017-06-30 13F Eli Lilly COM 532457108 7,765 200 2.64 639 0.47 0.1283
2017-05-15 2017-03-31 13F Eli Lilly COM 532457108 7,565 0 0.00 636 14.39 0.1285
2017-02-15 2016-12-31 13F Eli Lilly COM 532457108 7,565 705 10.28 556 0.91 0.1249
2016-11-15 2016-09-30 13F Eli Lilly COM 532457108 6,860 0 0.00 551 2.04 0.2093
2016-07-12 2016-06-30 13F Eli Lilly COM 532457108 6,860 1,521 28.49 540 40.63 0.2326
2016-05-13 2016-03-31 13F/A-1 Eli Lilly COM 532457108 5,339 66 1.25 384 -13.51 0.1935
2016-05-13 2016-03-31 13F Eli Lilly COM 532457108 5,339 384
2016-02-04 2015-12-31 13F Eli Lilly COM 532457108 5,273 185 3.64 444 4.23 0.2400
2015-11-04 2015-09-30 13F Eli Lilly COM 532457108 5,088 470 10.18 426 11.52 0.2381
2015-07-31 2015-06-30 13F Eli Lilly COM 532457108 4,618 547 13.44 382 29.05 0.1821
2015-05-14 2015-03-31 13F Eli Lilly COM 532457108 4,071 4,071 296 0.1484
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.